Using simple vital-sign scores to guide care for COVID-19 patients
Official title: The Combined Usage of Clinical Physiological Finding in Management of COVID 19 Patients
Run by St. Martin De Porress Hospital · NCT07504341 · Data updated 2026-11-12
This project tests whether simple vital-sign scores (like shock index, modified and respiratory-adjusted shock indices) can help track and predict worsening or improvement in people hospitalized with COVID-19.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 15000 (estimated) |
| Sponsor | St. Martin De Porress Hospital Academic / other |
| Locations | 2 sites (Tainan, Taiwan and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | March 11, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07504341 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People hospitalized with COVID-19 at the participating St. Martin De Porres Hospital sites between May 2022 and March 2027 who have complete vital-sign records (blood pressure, heart rate, respiratory rate, and level of consciousness) are the intended candidates.
✕Probably not a fit
Patients with incomplete or missing clinical records, those treated entirely outside the May 2022–March 2027 window, or cases lacking the required vital-sign data would not be included and are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses routinely recorded physiological data—blood pressure, heart rate, respiratory rate, and level of consciousness—from patients treated at the participating hospitals between May 2022 and March 2027. Investigators will calculate indices such as Shock Index, Modified Shock Index, Age Shock Index, Age Modified Shock Index, and Respiratory Adjusted Shock Index and compare them to clinical courses. The work aims to develop easy-to-use bedside or electronic tools, potentially aided by artificial intelligence, to flag early deterioration and guide timely treatment. The approach is intended for settings with varied illness severity and limited manpower to support rapid triage and monitoring.
Why it matters
Potential benefit: If successful, these simple, bedside or electronic scores could give earlier warning of clinical deterioration and help guide timely treatment and resource allocation.
How similar studies have gone: Shock-index approaches have shown usefulness in sepsis, trauma, and some COVID-19 cohorts, but respiratory-adjusted and certain age-modified indices are less widely validated and remain relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027 Exclusion Criteria: * Excluding patients with incomplete clinical data or missing information in their medical records.
Where it's running
-
St. Martin De Porres Hospital
Tainan, Taiwan, Taiwan Recruiting -
St. Martin De Porres Hospital
Chiayi City, Taiwan Recruiting
Study contacts
- Principal investigator: Chia-Hsi Chen, Physician — St. Martin De Porress Hospital
- Study coordinator: Chia-Hsi Chen, Physician
- Email: urologist3509@gmail.com
- Phone: 886-5-2756000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding heart function in COVID-19 survivors using MRI
This study is trying to see how heart scans can help understand heart function and long-term symptoms in people who have survived COVID-19.
-
Using Molnupiravir to Prevent Severe COVID-19 in High-Risk Individuals
This study is testing if the medication molnupiravir can help prevent severe COVID-19 in high-risk individuals who have recently shown symptoms of the virus.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.